Provided by Tiger Trade Technology Pte. Ltd.

ESSEX BIO-TECH

4.300
-0.150-3.37%
Volume:310.00K
Turnover:1.35M
Market Cap:2.44B
PE:8.09
High:4.410
Open:4.400
Low:4.290
Close:4.450
52wk High:6.039
52wk Low:2.600
Shares:567.00M
HK Float Shares:567.00M
Volume Ratio:0.70
T/O Rate:0.05%
Dividend:0.13
Dividend Rate:3.02%
EPS(LYR):0.532
ROE:14.60%
ROA:7.83%
PB:1.07
PE(LYR):8.09
PS:1.42

Loading ...

HK Stock Movement | ESSEX BIO-TECH (01061) Rises Nearly 9% in Afternoon Session; Company to Showcase Multiple Core Ophthalmology Products at APAO 2026

Stock News
·
Jan 27

BRIEF-Essex Bio-Technology's Unit Enters Exclusive Distribution Agreement With Osteopore International

Reuters
·
Jan 15

ESSEX BIO-TECH (01061) Enters Exclusive Distribution Agreement with OSTEOPORE

Stock News
·
Jan 15

Essex Bio-Technology - Distribution Agreement Has Expected Contract Value Exceeding RMB12 Mln

THOMSON REUTERS
·
Jan 15

Essex Bio-Technology Signs Exclusive Distribution Deal with Osteopore Worth Over RMB12 Million

Reuters
·
Jan 15

ESSEX BIO-TECH (01061): Multi-Dose Sodium Hyaluronate Eye Drops (0.3%) Approved for Commercialization in China

Stock News
·
Jan 09

Essex Bio-Technology Ltd - Biounit Receives Approval for Multi-Dose Sodium Hyaluronate Eye Drops From Nmpa

THOMSON REUTERS
·
Jan 09

Essex Bio-Technology Ltd - Received Approval for Registration & Commercialisation of the Approved Product

THOMSON REUTERS
·
Jan 09

Essex Bio-Technology Wins Approval to Commercialise Sodium Hyaluronate Eye Drops in China

Reuters
·
Jan 09

Essex Bio-Technology (01061) Announces Monthly Return for November 2025, Reports No Changes in Issued Shares

Bulletin Express
·
Dec 02, 2025

Essex Bio-Technology (01061) Announces Monthly Return for October 2025

Bulletin Express
·
Nov 04, 2025

BRIEF-Essex Bio-Technology To Declare Interim Dividend HK$0.07 Per Share

Reuters
·
Aug 26, 2025

ESSEX BIO-TECH (01061) Reports Interim Results with Profit of HK$163 Million, Up 3.79% Year-on-Year

Stock News
·
Aug 26, 2025

Essex Bio-Technology Ltd - Declares an Interim Dividend of HK$0.07 per Share

THOMSON REUTERS
·
Aug 26, 2025

Essex Bio-Technology H1 Net Income HKD 163.4 Million

THOMSON REUTERS
·
Aug 26, 2025